FDA Inspection 1178629 — Y-mAbs Therapeutics A/S
The FDA completed an inspection of Y-mAbs Therapeutics A/S on Aug 16, 2022 in Horsholm. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 16, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Horsholm (Denmark)
Additional Details
Sponsor, Contract Research Organization